Year |
Citation |
Score |
2024 |
Lépine B, Debin M, Dassieu L, Gimenez L, Palmaro A, Ponté C, Swital M, Lapeyre-Mestre M, Blanchon T, Dupouy J. GPs' practices when prescribing buprenorphine in primary care: A survey among the Sentinelles network. Therapie. PMID 38729825 DOI: 10.1016/j.therap.2024.04.002 |
0.415 |
|
2022 |
Lépine B, Debin M, Dassieu L, Gimenez L, Palmaro A, Ponté C, Swital M, Lapeyre-Mestre M, Blanchon T, Dupouy J. Prescribing buprenorphine for opioid use disorder in primary care: A survey of French general practitioners in the Sentinelles network. Journal of Substance Abuse Treatment. 143: 108891. PMID 36215914 DOI: 10.1016/j.jsat.2022.108891 |
0.437 |
|
2022 |
Lavergne J, Debin M, Blanchon T, Colizza V, Dassieu L, Gimenez L, Kengne-Kuetche C, Lapeyre-Mestre M, Dupouy J. Perceived risk of opioid use disorder secondary to opioid analgesic medication use by the general population in France. European Journal of Pain (London, England). 26: 729-739. PMID 34958720 DOI: 10.1002/ejp.1901 |
0.449 |
|
2020 |
Escourrou E, Durrieu F, Chicoulaa B, Dupouy J, Oustric S, Andrieu S, Gardette V. Cognitive, functional, physical, and nutritional status of the oldest old encountered in primary care: a systematic review. Bmc Family Practice. 21: 58. PMID 32220228 DOI: 10.1186/S12875-020-01128-7 |
0.589 |
|
2020 |
Dupouy J, Maumus-Robert S, Mansiaux Y, Pariente A, Lapeyre-Mestre M. Primary Care of Opioid use Disorder: The End of "the French Model"? European Addiction Research. 1-9. PMID 32155620 DOI: 10.1159/000506630 |
0.516 |
|
2019 |
Jouanjus E, Lapeyre-Mestre M, Nodot M, Roussin A, Franchitto N, Boyes JP, Nasr N, Oustric S, Dupouy J. Teaching Basic Knowledge on Substance Use Disorders: the Impact of e-Learning on Health Professionals. Clinical Therapeutics. PMID 31395392 DOI: 10.1016/J.Clinthera.2019.07.012 |
0.668 |
|
2019 |
Driot D, Ouhayoun S, Perinelli F, Grézy-Chabardès C, Birebent J, Bismuth M, Dupouy J. Non-drug and drug alternatives to benzodiazepines for insomnia in primary care: Study among GPs and pharmacies in a Southwest region of France. Therapie. PMID 31030902 DOI: 10.1016/J.Therap.2019.03.004 |
0.341 |
|
2019 |
Driot D, Jouanjus E, Oustric S, Dupouy J, Lapeyre-Mestre M. Patterns of gabapentin and pregabalin use and misuse: results of a population-based cohort study in France. British Journal of Clinical Pharmacology. PMID 30737829 DOI: 10.1111/Bcp.13892 |
0.666 |
|
2018 |
Dupouy J, Vergnes A, Laporte C, Kinouani S, Auriacombe M, Oustric S, Rougé Bugat ME. Intensity of previous teaching but not diagnostic skills influences stigmatization of patients with substance use disorder by general practice residents. A vignette study among French final-year residents in general practice. The European Journal of General Practice. 24: 160-166. PMID 29792534 DOI: 10.1080/13814788.2018.1470239 |
0.363 |
|
2018 |
Pochard L, Dupouy J, Frauger E, Giocanti A, Micallef J, Lapeyre-Mestre M. Impact of pregnancy on psychoactive substance use among women with substance use disorders recruited in addiction specialized care centers in France. Fundamental & Clinical Pharmacology. PMID 29337399 DOI: 10.1111/Fcp.12346 |
0.503 |
|
2017 |
Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Mortality Associated With Time in and Out of Buprenorphine Treatment in French Office-Based General Practice: A 7-Year Cohort Study. Annals of Family Medicine. 15: 355-358. PMID 28694272 DOI: 10.1370/Afm.2098 |
0.501 |
|
2017 |
Palmaro A, Boucherie Q, Dupouy J, Micallef J, Lapeyre-Mestre M. Immeasurable time bias due to hospitalization in medico-administrative databases: which impact for pharmacoepidemiological studies? Pharmacoepidemiology and Drug Safety. PMID 28266748 DOI: 10.1002/Pds.4193 |
0.477 |
|
2017 |
Dupouy J, Lapeyre-Mestre M, Oustric S. Psychiatric disorders as predictors of long-term opioid therapy and the need for treating chronic pain correctly in patients with prior opioid substance use disorder: a commentary. Pain. 158: 6-7. PMID 27764036 DOI: 10.1097/J.Pain.0000000000000748 |
0.481 |
|
2017 |
Dupouy J, Palmaro A, Fatséas M, Auriacombe M, Micallef J, Oustric S, Lapeyre-Mestre M. Mortalité associée aux périodes sous et hors traitement par buprénorphine Therapies. 72: 164. DOI: 10.1016/J.Therap.2016.11.041 |
0.443 |
|
2017 |
Driot D, Palmaro A, Dupouy J, Oustric S, Jouanjus E, Lapeyre-Mestre M. Patterns of Use of Pregabalin and Gabapentin in France: A Cohort Study of New Users on a French Representative Sample Clinical Therapeutics. 39: e52-e53. DOI: 10.1016/J.Clinthera.2017.05.163 |
0.654 |
|
2017 |
Palmaro A, Patras de Campaigno E, Dupui M, Baricault B, Dupouy J, Despas F, Lapeyre-Mestre M. Identifying Potential Drug–Drug Interactions In The French Health Insurance Databases: Application In Multiple Myeloma Patients Clinical Therapeutics. 39: e33. DOI: 10.1016/J.Clinthera.2017.05.103 |
0.45 |
|
2016 |
Driot D, Chicoulaa B, Jouanjus E, Dupouy J, Oustric S, Lapeyre-Mestre M. Pregabalin use disorder and secondary nicotine dependence in a woman with no substance abuse history. Therapie. 71: 575-578. PMID 27473599 DOI: 10.1016/J.Therap.2016.04.006 |
0.677 |
|
2016 |
Palmaro A, Moulis G, Despas F, Dupouy J, Lapeyre-Mestre M. Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies. Fundamental & Clinical Pharmacology. 30: 616-624. PMID 27351637 DOI: 10.1111/Fcp.12214 |
0.509 |
|
2016 |
Bossard JB, Ponté C, Dupouy J, Lapeyre-Mestre M, Jouanjus E. Disproportionality Analysis for the Assessment of Abuse and Dependence Potential of Pregabalin in the French Pharmacovigilance Database. Clinical Drug Investigation. PMID 27300651 DOI: 10.1007/S40261-016-0421-Z |
0.67 |
|
2016 |
Breu-Dejean N, Driot D, Dupouy J, Lapeyre-Mestre M, Rostaing L. Efficacy of Psychoeducational Intervention on Allograft Function in Kidney Transplant Patients: 10-Year Results of a Prospective Randomized Study. Experimental and Clinical Transplantation : Official Journal of the Middle East Society For Organ Transplantation. 14: 38-44. PMID 26862823 |
0.355 |
|
2016 |
Boucherie Q, Dupouy J, Micallef J, Lapeyre-Mestre M, Palmaro A. Périodes d’exposition inobservables au cours des séjours hospitaliers en PMSI MCO : quel impact pour les études pharmacoépidémiologiques ? Revue D'éPidéMiologie Et De Santé Publique. 64: S29-S30. DOI: 10.1016/J.Respe.2016.01.004 |
0.426 |
|
2015 |
Grézy-Chabardès C, Fournier JP, Dupouy J, Poutrain JC, Oustric S. Patients' Knowledge About Analgesic-Antipyretic Medications Purchased in Community Pharmacies: A Descriptive Study. Journal of Pain & Palliative Care Pharmacotherapy. 29: 334-40. PMID 26524132 DOI: 10.3109/15360288.2015.1082007 |
0.301 |
|
2015 |
Palmaro A, Dupouy J, Lapeyre-Mestre M. Benzodiazepines and risk of death: Results from two large cohort studies in France and UK. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 25: 1566-77. PMID 26256008 DOI: 10.1016/J.Euroneuro.2015.07.006 |
0.495 |
|
2014 |
Birebent J, Dupouy J, Bismuth M, Magnaval V, Despas F, Alquier V, Oustric ES. [Not Available]. Therapie. 69: 401-17. PMID 27392883 DOI: 10.2515/Therapie/2014053 |
0.325 |
|
2014 |
Dupouy J, Mémier V, Catala H, Lavit M, Oustric S, Lapeyre-Mestre M. Does urine drug abuse screening help for managing patients? A systematic review. Drug and Alcohol Dependence. 136: 11-20. PMID 24417964 DOI: 10.1016/J.Drugalcdep.2013.12.009 |
0.501 |
|
2014 |
Dupouy J, Fournier JP, Jouanjus E, Palmaro A, Poutrain JC, Oustric S, Lapeyre-Mestre M. Baclofen for alcohol dependence in France: Incidence of treated patients and prescription patterns-A cohort study European Neuropsychopharmacology. 24: 192-199. PMID 24139234 DOI: 10.1016/J.Euroneuro.2013.09.008 |
0.668 |
|
2013 |
Dupouy J, Moulis G, Tubery M, Ecoiffier M, Sommet A, Poutrain JC, Arlet P, Lapeyre-Mestre M. Which adverse events are related to health care during hospitalization in elderly inpatients? International Journal of Medical Sciences. 10: 1224-30. PMID 23935400 DOI: 10.7150/Ijms.6640 |
0.588 |
|
2013 |
Dupouy J, Bez J, Barsony J, Oustric S, Lapeyre-Mestre M. [Opiate substitution treatment's cycles in a five-year followed-up cohort in ambulatory practice]. Therapie. 68: 155-61. PMID 23886460 DOI: 10.2515/Therapie/2013022 |
0.463 |
|
2013 |
Dupouy J, Dassieu L, Bourrel R, Poutrain JC, Bismuth S, Oustric S, Lapeyre-Mestre M. Effectiveness of drug tests in outpatients starting opioid substitution therapy. Journal of Substance Abuse Treatment. 44: 515-21. PMID 23337248 DOI: 10.1016/J.Jsat.2012.11.006 |
0.497 |
|
2012 |
Fournier JP, Lapeyre-Mestre M, Sommet A, Dupouy J, Poutrain JC, Montastruc JL. Laboratory monitoring of patients treated with antihypertensive drugs and newly exposed to non steroidal anti-inflammatory drugs: a cohort study. Plos One. 7: e34187. PMID 22479557 DOI: 10.1371/Journal.Pone.0034187 |
0.6 |
|
2012 |
Dupouy J, Bismuth S, Oustric S, Lapeyre-Mestre M. On-site drugs of abuse urinary screening tests for the management of opiate-addicted patients: a survey among French general practitioners. European Addiction Research. 18: 175-83. PMID 22440979 DOI: 10.1159/000336540 |
0.505 |
|
2011 |
Dupouy J, Poutrain JC, Lapeyre-Mestre M. [Naltrexone and opiate substitutive treatment]. Therapie. 66: 549-52. PMID 22691393 DOI: 10.2515/Therapie/2011072 |
0.465 |
|
2011 |
Dupouy J, Moulis G, Tubery M, Ecoiffier M, Sommet A, Poutrain J, Arlet P, Lapeyre-Mestre M. Iatrogénie intra-hospitalière dans un service de médecine interne - post-urgences médicales La Revue De MéDecine Interne. 32: S61. DOI: 10.1016/J.Revmed.2011.03.051 |
0.52 |
|
Show low-probability matches. |